Drug Discovery News - April 17, 2022
Nicholas Baker, Ph.D., discusses a study that discovered how epithelial cells interact with precancerous cells, recognizing them and removing them from the body. Dr. Baker is professor of genetics, of developmental and molecular biology, and of ophthalmology and visual sciences, and is the Harold and Muriel Block Chair in Genetics.
Dr. Baker's ProfileMore coverage on Dr. Baker
Healio - January 26, 2022
Tiffany Lu, M.D., M.S., describes her grant that will fund the expansion of addiction medicine and training programs for medical students and residents at Einstein and Montefiore. The curriculum will focus on the diagnosis and care for people with opioid use disorder, including guidance about medications for addiction treatment, particularly buprenorphine. Dr. Lu is assistant professor of medicine at Einstein and director of the Montefiore Buprenorphine Treatment Network.
Dr. Lu's Profile
Review of Ophthamology - October 10, 2021
Roy Chuck, M.D., Ph.D., describes the benefits of a new contact lens-like device, patented by Montefiore and Einstein, that is used in a treatment for keratoconus, an eye disease that affects the structure of the cornea. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
Nature - September 2, 2020
In a commentary for Nature, Gary Schwartz, Ph.D., writes about the discovery of a pathway in the preoptic area of the brain in mice by which a light-sensitive protein regulates heat production. The findings may lead to ways of altering metabolism by manipulating environmental light. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
Dr. Ovryn's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile